1 / 44

Using Test Kit Allotments to Reduce Chlamydia Screening in Low Risk Females for Re-allocation to Higher Risk Populations

Using Test Kit Allotments to Reduce Chlamydia Screening in Low Risk Females for Re-allocation to Higher Risk Populations and Higher Yield Venues. Rabins C 1 , Holmes S 1 , Renier E 1 , Zimmerman R 1, Sylvester T 2 1 STD Program, Illinois Department of Public Health, Springfield, IL, USA

randilyn
Download Presentation

Using Test Kit Allotments to Reduce Chlamydia Screening in Low Risk Females for Re-allocation to Higher Risk Populations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Using Test Kit Allotments to Reduce Chlamydia Screening in Low Risk Females for Re-allocation to Higher Risk Populations and Higher Yield Venues Rabins C1, Holmes S1, Renier E1, Zimmerman R1, Sylvester T2 1STD Program, Illinois Department of Public Health, Springfield, IL, USA 2Division of Laboratories, Illinois Department of Public Health, Springfield, IL, USA

  2. Abstract Using Test Kit Allotments to Reduce Chlamydia Screening in Low Risk Females for Re-allocation to Higher Risk Populations and Higher Yield Venues Charlie Rabins1, Stephen Holmes1, Edward Renier1, Richard Zimmerman1, and Tony Sylvester2. (1) Sexually Transmitted Diseases Program, Illinois Department of Public Health, 525 W. Jefferson, Springfield, IL, USA, (2) Division of Laboratories, Illinois Department of Public Health, 825 N. Rutledge, Springfield, IL, USA Background:Illinois STD-Related Infertility Prevention Project (IIPP) selective screening criteria recommend that sexually active females attending IIPP screening sites receive a test for chlamydia at least annually if they are either under 25 years of age or 25 years of age and older with a risk factor. An analysis of chlamydia screening data among females at selected IIPP screening sites during 2000 to 2004 indicated that an annual average of 55,691 (38.7%) chlamydia tests were among females 25 years of age and older at a projected cost of $696,138.Objective: To assess the use of test kit allotments to reduce chlamydia testing in females not meeting the selective screening criteria enabling expanded testing in higher risk populations and higher yield venues.Method: IIPP chlamydia screening data among females for 2004 was analyzed by age group and an allocation algorithm was developed and implemented in 2005 to encourage increased testing among females under 25 years of age and males while reducing testing in females 25 years of age and older with no identified risk factors.Result: A preliminary analysis of 2005 IIPP testing data (year 1 - implementation) indicates that testing in females 25 years of age and older was reduced by 14.6% (7,733 tests) enabling these tests to be available for re-allocation to higher risk populations and higher yield venues or a reduction in testing costs of up to $96,663.Conclusion: Implementing test kit allotments is an effective strategy to reduce chlamydia testing in low risk females enabling expanded testing in higher risk populations and higher yield venues.Implications: In an era of level or decreased funding for chlamydia screening, reducing testing in low risk females can free up resources for expanding testing in higher risk populations and higher yield venues without increased funding.

  3. Background -1 Illinois Infertility Prevention Project (IPP) Resources - 2004 • Tests = 222,516 • Females: 168,565: 76% Tests (7.2% Pos) • Males: 53,843: 24% Tests (11.3% Pos) • Costs • Testing ~ $2.8 Million • Staffing ~ $100,000 • Funding • Federal ~ $1.1 Million • State ~ $1.8 Million • Title X FP ~ $300,000 (Lab and Clinic Support) • Cook County Jail – 22,289 Tests in 2005 • 37 Providers Pay for Tests (3,250)

  4. Background -2IllinoisIPP Chlamydia Testing Females By Testing Site Type, 2004 * Excludes several low volume site types

  5. Background -3 • Decreasing Federal & State Funding in 2003 Prevented: • Expanding Testing Among Females & Males In High Yield Populations and Venues • Expanding Urine Based Testing • Implementing Retesting for Positive Females • Anecdotal Data Suggested Significant Amount of IPP Testing in Low Yield Populations With Low Predictive Value Positives • Attempts to Encourage Voluntary Adherence to IPP Screening Guidelines Were Overall Unsuccessful

  6. In difficult times use a mirror, you will find both cause andresolution! Source: 365 Tao: Daily Meditations – Deng Ming-Dao

  7. Background - 4 • The Illinois Infertility Prevention Project (IPP) Screening Criteria recommends testing: • all sexually active females 24 years of age and younger for chlamydia and gonorrhea at least annually • females 25 years of age and older who have one or more risk factors

  8. Background - 5 Risk Factors for Females 25 Years of Age and Older • STD Signs or Symptoms • Vaginal Discharge • Mucopurulent Cervicitis • Pelvic Inflammatory Disease • Sex Partner of Person Recently Diagnosed With Chlamydia or Gonorrhea • Sex Partner Risk (within past 3 months) • New sex partner • >1 sex partner • Sex partner with additional sex partners • Prior STD History in Past 3 years • IUD Insertion • Pregnancy

  9. Objective • Determine if Evidence Based Test Kit Allotments to Illinois IPP Chlamydia Screening Sites Reduces Testing in Low Risk Females 25 Years of Age and Older

  10. Methods-1 • Analyzed 4 Yrs Testing Data By Testing Site Type By Sex and Age Group to Determine Extent of Testing in Females 25 Years of Age and Older

  11. IPP* Chlamydia Testing In FemalesBy Age Group, Illinois, 2000 to 2003 % Positive % Positive % Total Tests % Total Tests *IPP – Infertility Prevention Project

  12. IPP Chlamydia Testing In FemalesAt Illinois Family Planning Clinics By Age Group, Illinois, 2000 to 2003 % Total Tests % Positive

  13. RVIPP* Chlamydia Testing In FemalesBy Age Group, FP Clinics, 1998 to 2003 % Total Tests % Positive RVIPP = Region V Infertility Prevention Project: Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin

  14. RVIPP Chlamydia Testing In Females, 2005 Family Planning Clinics By State & Age Group % Total Tests % Positive

  15. 90,600 Tests 8,270 Positives Identified (9.1%) Assume $12.50 per NAAT $1,132,500 $137 per Positive Identified 55,981 Tests 1,833 Positives Identified (3.3%) Assume $12.50 per NAAT $699,762 $382 per Positive Identified 2003 Illinois IPP Estimated Testing CostsAll Screening Sites*, Females By Age Group Under Age 25 Ages 25 and Older * Testing by IDPH Labs and Excludes Payors and CCDPH FP

  16. 58,185 Tests 4,317 Positives Identified (7.4%) Assume $12.50 per NAAT $727,312 $168 per Positive Identified 25,718 Tests 791 Positives Identified (3.0%) Assume $12.50 per NAAT $321,475 $406 per Positive Identified 2003 Illinois IPP Estimated Testing CostsFamily Planning Clinics*, Females By Age Group Under Age 25 Ages 25 and Older * Testing by IDPH Labs and Excludes CCDPH FP and Payors

  17. Illinois IPP Chlamydia Testing in 2003Females 25 Years of Age and OlderProjected Laboratory Testing CostsBefore Implementation of Allotment Systems Criteria = Selective Screening Criteria

  18. Methods-2 • Developed List of Potential Reallocation Options/Methods With Pros and Cons • Tested Models to Determine Optimal Testing Reallocation and Algorithm • Presented Data to IPP Partners to Gain Support and Reach Consensus on Methodology and Algorithm

  19. Illinois IPP Chlamydia Test Kit Allotment Algorithm By Testing Site Type *STD clinics >= 27 years 110% = Increase in Test Kits

  20. Methods-3 • Determined that Controlling Test Kits Shipped to Testing Sites By IDPH Lab Was Best Strategy for Illinois IPP • Obtained Approval From IDPH Administration & Warned About Disgruntled Sites & Blowback • Developed Implementation Needs, Plan and Timeline • Data Systems Needed to Link & Monitor Lab Testing & Test Kit Ordering • Communication and Marketing to Testing Sites

  21. Results Summary • Reduction in Testing Among Females Ages >=25 at Family Planning (22%) and NonFamily Planning (20%) Clinics • Reduction in Positive Tests Among Females Ages >=25 at Family Planning (19%) and NonFamily Planning (20%) Clinics • Increase (45%) in Adherence to Selective Screening Criteria • 11,493 Fewer Test Among Females Ages >=25 Now Available for Expansion in Higher Risk Populations and Venues (355 Fewer Positive Tests Detected) • 2,973 Fewer Tests Among Females Ages <25 and 246 Fewer Positive Tests Detected

  22. Illinois IPP Chlamydia Testing 2003 & 2005Females 25 Years of Age and OlderFamily Planning Clinics*Change in Screening Criteria Adherence and Projected Laboratory Testing Costs * Includes Title X and non-Title X – excluding CCDPH and Payors

  23. Illinois IPP Chlamydia Testing Females 25 Years of Age & OlderFamily Planning vs. NonFamily Planning PR = Positivity Rate NonFP = Non Family Planning Clinics

  24. Illinois IPP Chlamydia Testing Females Under 25 Years of AgeFamily Planning vs. NonFamily Planning PR = Positivity Rate NonFP = Non Family Planning Clinics

  25. Chlamydia Tests In FemalesAll IPP Testing Sites, By Age Group, Illinois, 2003 vs. 2005

  26. Chlamydia Positives In FemalesAll IPP Testing Sites, By Age Group, Illinois, 2003 vs. 2005

  27. Conclusions • Implementing Test Kit Allotments Is an Effective Strategy to Reduce Testing in Low Risk Females • Allotments May Contribute to Unintended Reduction in Testing Among Higher Risk Women Under 25 Years of Age • Reanalysis of Age Specific Screening Criteria for Illinois IPP Is Needed With Possible Increase to Age 32 for Females At Some Sites

  28. Lessons Learned - 1 • Support from Partners & Leaders Essential • Implement Allotments at Beginning of Year • Notify Sites of Allotment 2-3 Months Prior to Implementation & Provide Rationale and Site Specific Retrospective Data • Call or Meet With Sites With High Percentage of Low Yield Testing Prior to Implementation • After Implementation, Review & Provide Prospective Data At Least Quarterly and Call Sites with Adherence Problems

  29. Lessons Learned - 2 • Expect Unintended Benefits & Challenges • Flexibility & Patience Required – One Size Doesn’t Fit All • Documenting Activities and Outcomes Facilitates Evaluation and Information Transfer • Implementing, Managing and Monitoring Test Kit Allotments Is Very Labor Intensive

  30. Acknowledgements • Steve Holmes – Allotment Database Development & Data Tabulation • Ed Renier – Allotment Enforcement • IDPH STD Program & Lab Staff • IDPH Administration • IPP Members & Testing Site Staff • RVIPP Members & HCET • Alfred E. Neuman – Mentoring

  31. IPP Chlamydia Allotment Project Recipient of Illinois Department of Public Health 2005 Exceptional Achievement Award

  32. Presentation AddendumTest Kit Utilization & Allotment Data Base Images

More Related